Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Vet J ; 272: 105659, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-33941330

RESUMO

Additives used to improve feed efficiency of beef cattle on high-grain diets requires products that not only increase animal performance but also provide food safety for consumers. Since phytogenic additives such as essential oils (EO) are the main substitutes for monensin in the diet of cattle fed high-grain diets, this study aimed to evaluate, through meta-analysis, the effects of EO as an alternative to monensin in diets for beef cattle on feed intake, performance, carcass characteristics and ruminal fermentative parameters. Ten peer-reviewed publications with 27 treatment means were included in the data set. These effects were evaluated using random-effect models to examine the weighted mean differences (WMD) between EO treatment and control treatment (diets with monensin). Heterogeneity was explored by meta-regression and subgroup analysis. The substitution of EO for monensin did not affect methane production, ruminal pH values, average daily gain, feed efficiency or carcass weight. However, carcass dressing percentage (WMD = 0.38%; P = 0.03), ribeye area (WMD = 0.82 cm2; P < 0.0001) and subcutaneous fat thickness (WMD = 0.56 mm; P < 0.0001) values increased. Although the use of EO instead of monensin had no influence on the performance of beef cattle fed high-grain diets, the prevalence of hepatic abscesses increased 84.9% and the replacement of monensin by EO increased the risk ratio of hepatic abscess prevalence by 107%. Therefore, the use of EO in high-grain beef cattle diets was ineffective in protecting the liver against abscesses.


Assuntos
Bovinos/fisiologia , Dieta/veterinária , Monensin/administração & dosagem , Óleos Voláteis/administração & dosagem , Ração Animal/análise , Animais , Doenças dos Bovinos/epidemiologia , Digestão , Ingestão de Alimentos , Grão Comestível , Fermentação , Aditivos Alimentares , Abscesso Hepático/epidemiologia , Abscesso Hepático/veterinária , Rúmen/metabolismo
2.
Vet Pathol ; 48(1): 169-81, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21160022

RESUMO

Molecular assays are widely used to prognosticate canine cutaneous mast cell tumors (MCT). There is limited information about these prognostic assays used on MCT that arise in the subcutis. The aims of this study were to evaluate the utility of KIT immunohistochemical labeling pattern, c-KIT mutational status (presence of internal tandem duplications in exon 11), and proliferation markers--including mitotic index, Ki67, and argyrophilic nucleolar organizing regions (AgNOR)--as independent prognostic markers for local recurrence and/or metastasis in canine subcutaneous MCT. A case-control design was used to analyze 60 subcutaneous MCT from 60 dogs, consisting of 24 dogs with subsequent local recurrence and 12 dogs with metastasis, as compared to dogs matched by breed, age, and sex with subcutaneous MCT that did not experience these events. Mitotic index, Ki67, the combination of Ki67 and AgNOR, and KIT cellular localization pattern were significantly associated with local recurrence and metastasis, thereby demonstrating their prognostic value for subcutaneous MCT. No internal tandem duplication mutations were detected in exon 11 of c-KIT in any tumors. Because c-KIT mutations have been demonstrated in only 20 to 30% of cutaneous MCT and primarily in tumors of higher grade, the number of subcutaneous MCT analyzed in this study may be insufficient to draw conclusions on the role c-KIT mutations in these tumors.


Assuntos
Doenças do Cão/metabolismo , Regulação Neoplásica da Expressão Gênica/fisiologia , Mastocitoma/veterinária , Proteínas Proto-Oncogênicas c-kit/metabolismo , Neoplasias de Tecidos Moles/veterinária , Animais , Biomarcadores Tumorais , Estudos de Casos e Controles , Proliferação de Células , Doenças do Cão/genética , Cães , Feminino , Masculino , Mastocitoma/metabolismo , Prognóstico , Proteínas Proto-Oncogênicas c-kit/genética , Neoplasias de Tecidos Moles/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA